Kilpest India shines on selling 8.68 lakh Covid-19 RT-PCR tests in September

05 Oct 2020 Evaluate

Kilpest India is currently trading at Rs. 312.70, up by 6.10 points or 1.99% from its previous closing of Rs. 306.60 on the BSE.

The scrip opened at Rs. 309.00 and has touched a high and low of Rs. 312.70 and Rs. 306.60 respectively. So far 43939 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 517.00 on 12-Aug-2020 and a 52 week low of Rs. 54.00 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 312.70 and Rs. 277.70 respectively. The current market cap of the company is Rs. 234.78 crore.

The promoters holding in the company stood at 38.19% and Non-Institutions held 61.81%.

Kilpest India has sold 8.68 lakh Covid-19 RT-PCR tests in the month of September with an average price of Rs 230 per test. Earlier, in the month of August the company had sold 4.22 lakh Covid-19 RT-PCR test with an average price realisation of Rs 325 per test.

Kilpest India is one of India's leading agri-based companies. The Company manufactures, imports, exports, buys, and sells biological compounds derived from plants, animals, micro organisms.

3B Blackbio Dx Share Price

780.15 20.75 (2.73%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
UPL 505.90
BASF India 3602.00
PI Industries 3746.50
Bayer CropScience 5551.55
Sumitomo Chemical India 407.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.